Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

letter

. 2023 Mar 27;7(4):e867. doi: 10.1097/HS9.0000000000000867

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

Figure 1. — Blood counts and survival of MDS or MDS/MPN patients after danazol start. (A) PLT values (gray box plots) and Hb levels (red box plots) overtime from danazol start. Only Hb values from patients with baseline Hb <110 g/L were reported. (B) Overall survival of PLT-responders vs nonresponders. Survival was censored at 40 mo from danazol start. Hb = hemoglobin; PLT = platelet.